Showing results (371-380 of 735) with videos related to

Sort By:
Pageof 74
European Journal of Internal Medicine|March 25, 2025
Excess mortality of critically ill patients aged ≥90 years in intensive care units: A retrospective cohort studyJan Frederic Weller, Kevin Roedl, Rikus Daniels, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2008
Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on primingDjordje Atanackovic, Nasser K Altorki, Yanran Cao, et al.
Plos One|July 30, 2024
Improvements in hematologic markers and decreases in fatigue with pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and mild or moderate anemia (hemoglobin ≥10 g/dL) who had received eculizumab or were naive to complement inhibitorsJens Panse, Nicolas Daguindau, Sonia Okuyama, et al.
Experimental Hematology|April 27, 2005
Telomere length and telomerase activity in the BCR-ABL-transformed murine Pro-B cell line BaF3 is unaffected by treatment with imatinibUlrike Hartmann, Stefan Balabanov, Patrick Ziegler, et al.
Cancers|June 10, 2022
Diagnostic Utility of Bronchoalveolar Lavage in Patients with Acute Leukemia under Broad-Spectrum Anti-Infective TreatmentSusanne Ghandili, Philipp H von Kroge, Marcel Simon, et al.
Plos One|July 11, 2014
Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapseJan K Hennigs, Julia Müller, Matti Adam, et al.
Applied Health Economics and Health Policy|May 24, 2021
Developing a Framework for the Health Technology Assessment of Histology-independent Precision Oncology TherapiesJennifer G Gaultney, Jacoline C Bouvy, Richard H Chapman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trialMaria De Santis, Alexander Becherer, Carsten Bokemeyer, et al.
Hematology (Amsterdam, Netherlands)|January 2, 2026
Real-world clinical outcomes and treatment response in complement inhibitor experienced and naïve PNH patients prescribed pegcetacoplan in Europe and CanadaJens Panse, Juan Carlos Vallejo Llamas, Koo Wilson, et al.
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Serum levels of Magic Roundabout protein in patients with advanced non-small cell lung cancer (NSCLC)Michael Görn, Manuela Anige, Iris Burkholder, et al.
Pageof 74